2019 has been quite the year for UK pharma and healthcare, with these sectors experiencing unprecedented challenge, change and uncertainty. As the year’s last issue of PharmaTimes goes to press, and a general election looms ahead, the outlook for 2020 is still anyone’s guess (but more on that in the January/February edition!).
In our review of the year series, the team at Wilmington (p16) describes the momentous transformation of the NHS propelled by the introduction of a Long Term Plan. On page 30, Alantra’s Tom Cowap highlights a busy year for pharma M&A activity, with the stage set for more big deals to close early 2020. Also, Ana Nicholls offers an insightful look at the Brexit saga and its impact on pharma and healthcare (p33).
Our Business Insight with AbbVie on page 26 highlights the burden of rheumatoid arthritis and the continued pursuit of disease remission. Elsewhere, John Pinching gives his take on pharma sales forces past, present and future (p23).
There’s also a fascinating interview with Gilead’s Hillary Hutton-Squire (39), and on page 20 we celebrate the winners of the PharmaTimes Communications Team of the Year, Marketer of the Year and Sales Awards – congratulations to all who made it through to the finals! On that note, PharmaTimes is also delighted to announce the launch of the 10th Clinical Researcher of the Year 2020 – The Americas competition, see www.pharmatimes.com/ competitions for more information.
For decades intrepid pharma sales forces navigated the road network of Great Britain with little more than paper, pen and personality – hoping that one day the tools of their trade would mirror the cutting-edge science of the products they showcased. In recent years, the digital era has truly arrived, but as 2020 looms, big challenges still remain